In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial…
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in…
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the…
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen…
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across…
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at…
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder…
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme…
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its…
Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it has received the FDA’s approval for its…
